For the pharma industry, intellectual property rights play an essential role in the protection of innovative medicine from unauthorized imitation.
China's continuous efforts to safeguard IPR have solidified Takeda's confidence in investing in Shanghai, said Naoto Oizumi, legal senior patent counsel at Takeda China.
